RADIOSENSITIZING EFFICIENCY OF SODIUM GLYCIDIDAZOLE ON V79 CELLS IN VITRO
|更新时间:2023-04-23
|
RADIOSENSITIZING EFFICIENCY OF SODIUM GLYCIDIDAZOLE ON V79 CELLS IN VITRO
Journal of Radiation Research and Radiation ProcessingVol. 13, Issue 4, Pages: 213-218(1995)
作者机构:
1.第二军医大学放射医学研究室,上海 200433
1.第二军医大学电子计算机教研室,上海 200433
作者简介:
基金信息:
National Scientific Committee Foundation
DOI:
CLC:
扫 描 看 全 文
Zheng Xiulong, Gao Jianguo, Zhang Hong, et al. RADIOSENSITIZING EFFICIENCY OF SODIUM GLYCIDIDAZOLE ON V79 CELLS IN VITRO. [J]. Journal of Radiation Research and Radiation Processing 13(4):213-218(1995)
DOI:
Zheng Xiulong, Gao Jianguo, Zhang Hong, et al. RADIOSENSITIZING EFFICIENCY OF SODIUM GLYCIDIDAZOLE ON V79 CELLS IN VITRO. [J]. Journal of Radiation Research and Radiation Processing 13(4):213-218(1995)DOI:
RADIOSENSITIZING EFFICIENCY OF SODIUM GLYCIDIDAZOLE ON V79 CELLS IN VITRO
Radiosensitizing effect of sodium glycididazole (SGDD) on the hypoxic V,79, cells by standard in vitro colon formation method has been further studied. The results showed its toxicity was low. Its ID,50, in cells under hypoxic and aerobic condition were 23.5 and 35.7 mmol/L respectively. These indicated that SGDD showed more toxicity under hypoxic than that aerobic condition (,p,<,0.01). SGDD did not produce any radiosensitizing effect under air condition, however, irradiation under hypoxic SGDD showed radiosensitization and its SER increased as a function of drug concentration below 1.38 mmol/L. Its C,1.6, was 0.48 mmol/L. Its maxium SER was 2.3 at 1.38 mmol/L. Comparison of radiosensitizing effect of SGDD versus MISO and its mother compound (metronidazole) under the same experimental condition, SER for SGDD, MISO and metronidazole were 1.75, 1.53 and 1.07 at 0.3 mmol/L respectively. SGDD showed more radiosensitizing efficiency than MISO and much greater than metronidazole. This study further confirms our previous results i.e. SGDD is a hypoxic radiosensi tizer with low toxic, high efficiency and selectively enhances the radiosensitivity of hypoxic cells for tumor radiotherapy.